{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:57:24Z","timestamp":1777726644752,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No. 2022YFA1103501"],"award-info":[{"award-number":["No. 2022YFA1103501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical significance of alpha-fetoprotein and carbohydrate antigen 19-9 as potential predictors of outcomes in patients with acute liver failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of 208 patients with acute liver failure admitted to the intensive care unit between 2009 and 2023. Serum alpha-fetoprotein and carbohydrate antigen 19-9 levels were measured on Days 1 and 3, and their prognostic value was evaluated using logistic regression and receiver operating characteristic curve analyses. Patients were stratified by etiologies to assess biomarker performance across different causes of acute liver failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nonsurvivors had significantly lower alpha-fetoprotein levels and higher carbohydrate antigen 19-9 levels than survivors on Days 1 and 3 (all\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      &lt;\n                      <jats:italic toggle=\"yes\">\u2009<\/jats:italic>\n                      0.05). Alpha-fetoprotein levels increased over time in both groups, whereas carbohydrate antigen 19-9 levels increased in nonsurvivors and decreased in survivors. The combination of carbohydrate antigen 19-9 with the Model for End-Stage Liver Disease score significantly improved prognostic accuracy, with an area under the curve value of 0.828, compared with 0.784 for alpha-fetoprotein combined with Model for End-Stage Liver Disease score. Etiology-specific analysis revealed that carbohydrate antigen 19-9 showed the best predictive performance in acetaminophen-induced acute liver failure (area under the curve value\u2009=\u20090.885), whereas alpha-fetoprotein showed better predictive performance in viral hepatitis-associated acute liver failure (area under the curve value\u2009=\u20090.880).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Alpha-fetoprotein is a protective prognostic factor, whereas carbohydrate antigen 19-9 enhances outcome prediction, particularly when combined with Model for End-Stage Liver Disease score. Etiology-specific biomarker performance supports tailored prognostic approaches in the management of acute liver failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605251332808","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:31:54Z","timestamp":1745987514000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Alpha-fetoprotein and carbohydrate antigen 19-9 as prognostic biomarkers in acute liver failure: A retrospective study"],"prefix":"10.1177","volume":"53","author":[{"given":"Rui","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidan","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyi","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3323-1101","authenticated-orcid":false,"given":"Jinsong","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fifth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196903000-00003"},{"key":"e_1_3_9_3_2","first-page":"163","article-title":"Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria","volume":"6","author":"Shakil AO","year":"2000","unstructured":"Shakil AO, Kramer D, Mazariegos GV, et\u00a0al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163\u2013169.","journal-title":"Liver Transpl"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.016"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.OGX.0000099770.97668.18"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20948"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350200099"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.01.010"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2018.10.009"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v12.i12.468"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20511"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400491"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10541-w"},{"key":"e_1_3_9_15_2","article-title":"Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association","volume":"40","author":"Liver Failure and Artificial Liver Group,","year":"2024","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2024 version). J Clin Hepatol 2024; 40: 2371\u20132387.","journal-title":"J Clin Hepatol"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602678"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2015.01.005"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880019809167228"},{"key":"e_1_3_9_19_2","first-page":"135","article-title":"Elevated serum alpha-fetoprotein levels in non-alcoholic steatohepatitis: possible molecular mechanisms and potential clinical significance","volume":"22","author":"Wang Y","year":"2023","unstructured":"Wang Y, Cui X, Zhang H, et\u00a0al. Elevated serum alpha-fetoprotein levels in non-alcoholic steatohepatitis: possible molecular mechanisms and potential clinical significance. Gene Expr 2023; 22: 135\u2013140.","journal-title":"Gene Expr"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14216"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/0049475516653891"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120625"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2020.1725786"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12988"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2015.1115601"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750026461"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/531640"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.09.004"},{"key":"e_1_3_9_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27265"},{"key":"e_1_3_9_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28945"},{"key":"e_1_3_9_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfac015"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.002"},{"key":"e_1_3_9_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000665"},{"key":"e_1_3_9_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1073116"},{"key":"e_1_3_9_35_2","first-page":"80","article-title":"Traditional Chinese medicine-induced liver injury","volume":"2","author":"Teschke R.","year":"2014","unstructured":"Teschke R. Traditional Chinese medicine-induced liver injury. J Clin Transl Hepatol 2014; 2: 80\u201394.","journal-title":"J Clin Transl Hepatol"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251332808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605251332808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251332808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:47:19Z","timestamp":1777459639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605251332808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/03000605251332808"],"URL":"https:\/\/doi.org\/10.1177\/03000605251332808","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"article-number":"03000605251332808"}}